Emerging trends in invasive Streptococcus dysgalactiae subsp. equisimilis infections in Denmark, 2014 to 2024: a nationwide genomic and registry-based study
BACKGROUND Increasing incidence rates of invasive Streptococcus dysgalactiae subspecies equisimilis (iSDSE) have been detected worldwide. AIM We aimed to investigate iSDSE infection incidence rates in Denmark during 2014–2024, and characterise the genomic population structure of a subset of iSDSE isolates and their antimicrobial resistance (AMR). METHODS Using national register data, we estimated overall and sex-/age-stratified iSDSE incidences during 2014–2024, by retrospectively identifying cases of invasive infections with group C and G streptococci or S. dysgalactiae (including specified as subspecies equisimilis ). From the voluntary national beta-haemolytic streptococci laboratory surveillance system, whole-genome-sequenced isolates from August 2020−September 2022 were used to investigate the iSDSE genomic population structure. Susceptibility to penicillin, erythromycin and clindamycin was determined and AMR genes identified. RESULTS During 2014–2024, iSDSE incidence rates increased significantly (linear trend analysis p < 0.001) with mean annual incidence ranging between 10.3 and 16.4 per 100,000, peaking in 2023. Incidence was higher in males, increasing with older age. Nearly 75% of the 1,223 iSDSE isolates belonged to four of 14 genetic clusters. Sequence types (STs) ST20 and ST17 were most prevalent, while emm -type stG62647 , a variant associated internationally with higher virulence, dominated. All isolates were phenotypically susceptible to penicillin but approximately 10% were respectively erythromycin and clindamycin resistant. High erythromycin resistance prevalence (57%; 39/68), coinciding with gene ermA , occurred in one genetic cluster. CONCLUSION The findings illustrate the need for national registry-based surveillance to detect epidemiological changes and potential outbreaks. Further, continuous genomic surveillance can monitor the occurrence and expansion of genetic clades and AMR genes.
Authors
- David Fuglsang-Damgaard (ORCID: https://orcid.org/0000-0001-9123-5398)
- Raphael N. Sieber (ORCID: https://orcid.org/0000-0002-0372-128X)
- Thor Bech Johannesen (ORCID: https://orcid.org/0000-0003-4502-7883)
- Esad Dzajic
- Marc Stegger (ORCID: https://orcid.org/0000-0003-0321-1180)
- Aoife Ronayne
- Xiaohui Chen Nielsen (ORCID: https://orcid.org/0000-0003-4068-5748)
- Jana Grüttner (ORCID: https://orcid.org/0000-0002-2507-3375)
- Ulrich Stab Jensen (ORCID: https://orcid.org/0009-0003-7145-8182)
- Michael Pedersen (ORCID: https://orcid.org/0000-0002-1146-0382)
- Steen Hoffmann (ORCID: https://orcid.org/0000-0002-0614-2312)
- Claus Østergaard
- Lars MD Lemming
- Emma Julia Petronella Nilsson Gram
- Zahraa Chayed
- Marianna Konoy
Institutions
- Statens Serum Institut (DK)
- Murdoch University (AU)
- Aalborg University Hospital (DK)
- Amager Hospital (DK)
- Odense University Hospital (DK)
- Herlev Hospital (DK)
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
- Zealand University Hospital (DK)
- Vejle Sygehus (DK)
- Havstovan (FO)
- European Centre for Disease Prevention and Control (SE)
Publication Details
- Journal
- Eurosurveillance
- Published
- 2026-09-03
- DOI
- https://doi.org/10.2807/1560-7917.es.2026.31.35.2500714
- Primary Topic
- Streptococcal Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00